Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Works in Hematology · Metabolic & endocrine · Musculoskeletal · Oncology · Respiratory

Jiangsu Aosaikang Pharmaceutical Co., Ltd. is a clinical trial sponsor. It has 9 active clinical trials with 1,856 planned participants, across 5 therapeutic areas. Since 2021 it has completed 2 trials and stopped 0 early.

Trial track record · since 2021

9Active trials1,856 planned participants
2Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 9 active trials

StageTrialStatus

Questions about Jiangsu Aosaikang Pharmaceutical Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-27.

Approve Suite is not affiliated with Jiangsu Aosaikang Pharmaceutical Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.